iShares Russell 2000 Growth ETF Experiences Big Outflow

explosive growth image
From ETF Channel: Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed). Creation of new units will mean the underlying holdings of the ETF need to be purchased, while destruction of units involves selling underlying holdings, so large flows can also impact the individual components held within ETFs.
NYSE:IWO December 6, 2018 1:29pm

Stocks Remain Vulnerable To More Weakness (IWO, TLT, XLU, RWM, UUP, IYM, KOL, JJC)

wall-street-etfChris Ciovacco: An extended U.S. stock market was handed some bad European news Monday. From MarketWatch:
NYSE:IWO February 25, 2013 6:59pm

Which ETFs Performed Best During QE2? (SLV, IEZ, OIH, XES, XOP, XLE, KOL, XME, IWO, RSX, SMH)

Chris Ciovacco: If you are looking for an edge in terms of Thursday’s highly anticipated Fed announcement, the statements leading up to the announcement of QE2 in 2010 are an excellent place to start. Thus far, 2012 has not strayed far from the 2010 QE script,
NYSE:IEZ September 13, 2012 12:02pm

Current Stock Push Has Hurdles To Clear (XOP, EEM, EWG, EWJ, SCZ, IWM, IWO)

Chris Ciovacco:  The rally off the lows of last week has some work to do before it becomes convincing.  While the longer-term outlook remains favorable from a technical perspective, the conviction from buyers needs to pick up in the short-term.

NYSE:EEM March 12, 2012 10:58am

This Asset Class Returns 10-Times More Than The S&P 500 (IWN, IWO, IWM, SPY, DIA)

Tyler Laundon: If I told you that you could buy an asset class that soundly beat the S&P 500 index on a regular basis over the last ten years, you'd probably call me a liar - but at the very least you'd be intrigued.
NYSE:IWN December 20, 2011 4:37pm

ETF’S WITH A STAKE IN DENDREON CANCER VACCINE: IWM, IWO, IBB

dendreonNEW YORK (Reuters) - An experimental medicine from Dendreon Corp improved survival in men with advanced forms of prostate cancer, the company said on Tuesday, bolstering chances of it becoming the first approved therapeutic vaccine for any type of cancer. Shares of Dendreon (DNDN.O) more than tripled in heavy morning trading to as high as $22.10 as the study results suggested a revolutionary form of therapy is on the horizon for one of the most common cancers. Unlike traditional vaccines that prevent disease, the company's Provenge medicine treats it. "If you're in late stages of prostate cancer and your doctor says, 'You'll have no side effects with this drug and it will probably extend your life,' who's not going to take it?" said Sven Borho, an analyst with OrbiMed Advisors. The Phase III clinical trial met the main study goal of improving survival, prompting Dendreon to say it will seek U.S. regulatory approval of Provenge in the fourth quarter. "The successful outcome from the Phase 3 IMPACT study provides validation of the long-pursued goal of harnessing the human immune system against a patient's own cancer," Dendreon Chief Executive Mitchell Gold said in a statement. Prostate cancer is the most common cancer in American men other than skin cancers, according to the American Cancer Society. About one in six men will be diagnosed with prostate cancer during his lifetime. Full Story: http://www.reuters.com/article/hotStocksNews/idUSTRE53D4AB20090414
ETF BASIC NEWS April 14, 2009 2:08pm

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular


From Our Partners


Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories